New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Chemistry and Laboratory Medicine

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/CCLM.2011.634PMID 21671803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MALDI-TOF MS Combined With Magnetic Beads for Detecting Serum Protein Biomarkers and Establishment of Boosting Decision Tree Model for Diagnosis of Colorectal Cancer

  2011cited by this paper
• Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice.

  2010cited by this paper
• Tuberculosis: A Global Health Problem

  2010cited by this paper
• Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis

  2010cited by this paper
• Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

  2010cited by this paper
• MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.

  2010cited by this paper
• Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

  2010cited by this paper
• Novel technologies: A weapon against tuberculosis

  2010cited by this paper
• Proteomic profiling during atherosclerosis progression using SELDI-TOF-MS: effect of darbepoetin treatment.

  2010cited by this paper
• A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development.

  2010cited by this paper
• Tuberculosis 4 Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

  2010cited by this paper
• Biomarkers for tuberculosis disease activity, cure, and relapse.

  2009cited by this paper
• Discovery and identification of potential biomarkers of pediatric Acute Lymphoblastic Leukemia

  2009cited by this paper
• Serum Protein Profiling of Smear-Positive and Smear-Negative Pulmonary Tuberculosis Using SELDI-TOF Mass Spectrometry

  2009cited by this paper
• PROTEOMIC ANALYSIS IN CARDIOVASCULAR DISEASES

  2008cited by this paper
• Biomarker discovery in infectious diseases using SELDI.

  2007cited by this paper
• ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma.

  2007cited by this paper
• Molecular Cancer BioMed Central Review

  2007cited by this paper
• Proteomics Technologies and Challenges

  2007cited by this paper
• Contribution of oncoproteomics to cancer biomarker discovery

  2007cited by this paper
• Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry--plasma peptidomes from nasopharyngeal cancer patients for example.

  2006cited by this paper
• Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non‐diabetic rats

  2006cited by this paper
• Potential Biomarkers Found by Protein Profiling May Provide Insight for the Macrovascular Pathogenesis of Diabetes Mellitus

  2006cited by this paper
• Self-organizing neural projections

  2006cited by this paper
• Research progress in SELDI-TOF MS and its clinical applications

  2006cited by this paper
• Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome

  2006cited by this paper
• Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum

  2006cited by this paper
• Proteomic fingerprinting for the diagnosis of human African trypanosomiasis.

  2005cited by this paper
• Application of serum SELDI proteomic patterns in diagnosis of lung cancer

  2005cited by this paper
• Heart Disease, Clinical Proteomics and Mass Spectrometry

  2004cited by this paper
• SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.

  2004cited by this paper
• Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis

  2003cited by this paper
• SELDI-TOF MS for diagnostic proteomics.

  2003cited by this paper
• A Proteomic Approach to the Identification of Lung Cancer Markers

  2002cited by this paper
• Advances in diagnosis of tuberculosis

  1996cited by this paper

• Proteomics in Biomarker Discovery for Tuberculosis: Current Status and Future Perspectives

  2022cites this paper
• Mass spectrometry in the clinical laboratory. A short journey through the contribution to the scientific literature by CCLM

  2022cites this paper
• Use of Blood, Urine or Saliva-based Biomarkers in the Diagnosis of Active Pulmonary Tuberculosis-Sample Type Matters

  2021cites this paper
• Label-Free Quantitative Proteomics Identifies Novel Plasma Biomarkers for Distinguishing Pulmonary Tuberculosis and Latent Infection

  2018cites this paper
• Conventional and Molecular Diagnosis of Drug-Sensitive and Drug-Resistant Pulmonary Tuberculosis

  2018cites this paper
• Clinical MALDI mass spectrometry for tuberculosis diagnostics: speculating the methodological blueprint and contemplating the obligation to improvise

  2017cites this paper
• Diagnostic ‘omics’ for active tuberculosis

  2016cites this paper
• Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis.

  2015cites this paper
• Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ‐coupled two‐dimensional LC‐MS/MS

  2015cites this paper
• Early diagnosis of pulmonary tuberculosis using serum biomarkers

  2015cites this paper
• New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects.

  2014cites this paper
• Development of a potential high-throughput workflow to characterize sites of bioconjugation by immuno-affinity capture coupled to MALDI-TOF mass spectrometry.

  2013cites this paper
• Methods of searching for markers for serological serum diagnosis of tumors

  2013cites this paper
• Enzyme-linked immunospot assay response to recombinant CFP-10/ESAT-6 fusion protein among patients with spinal tuberculosis: implications for diagnosis and monitoring of surgical therapy.

  2013cites this paper
• [Serological diagnosis of tumors: methods of marker's search].

  2013cites this paper
• Serum Proteomics in Biomedical Research: A Systematic Review

  2013cites this paper
• Screening and Identification of Six Serum microRNAs as Novel Potential Combination Biomarkers for Pulmonary Tuberculosis Diagnosis

  2013cites this paper
• Biomarkers of tuberculosis: a research roadmap.

  2013cites this paper
• Clinical research and development of tuberculosis diagnostics: moving from silos to synergy.

  2012cites this paper